Inflammatory Bowel Diseases

The role of glucagon-like peptide 1 receptor agonists in the management of patients with inflammatory bowel diseases

By Poonam M. Beniwal-Patel, Sami Samaan, Maria Teresa Abreu, Parakkal Deepak, Andres J. Yarur

ReviewInterventions

The paper

Poonam M. Beniwal-Patel, Sami Samaan, Maria Teresa Abreu, Parakkal Deepak, Andres J. Yarur

Medical College of Wisconsin; Cedars-Sinai Medical Center

Inflammatory Bowel Diseases, 13 Aug 2026

doi.org/10.1093/ibd/izag151 PubMed 42593078

Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Neurology Genetics4 Oct 2026
GLP-1 receptor agonists link to lower stroke and Alzheimer risk
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity